Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Thromb Thrombolysis ; 46(1): 12-15, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29633066

RESUMO

Dabigatran is a direct thrombin inhibitor and a non-vitamin-K-antagonizing oral anticoagulant, approved for the prevention of stroke and systemic embolization in atrial fibrillation. Idarucizumab is a humanized monoclonal antibody that was recently approved for antagonizing the anticoagulant effects of dabigatran. Here, we report the use of idarucizumab in four acute stroke patients treated with dabigatran in order to enable intravenous thrombolysis in three patients and emergent trepanation in one patient with space occupying subdural hematoma. Since experience on the optimal management of acute stroke patients under medication with dabigatran and on the use of idarucizumab is currently limited, we propose an approach for laboratory testing and fast administration of intravenous thrombolysis and neurosurgery based on our experience.


Assuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Dabigatrana/uso terapêutico , Acidente Vascular Cerebral/tratamento farmacológico , Antitrombinas/uso terapêutico , Interações Medicamentosas , Hematoma Subdural , Humanos , Acidente Vascular Cerebral/cirurgia , Terapia Trombolítica , Trepanação
2.
Acta Neuropathol ; 134(1): 15-34, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28386765

RESUMO

Cortical demyelination is a widely recognized hallmark of multiple sclerosis (MS) and correlate of disease progression and cognitive decline. The pathomechanisms initiating and driving gray matter damage are only incompletely understood. Here, we determined the infiltrating leukocyte subpopulations in 26 cortical demyelinated lesions of biopsied MS patients and assessed their contribution to cortical lesion formation in a newly developed mouse model. We find that conformation-specific anti-myelin antibodies contribute to cortical demyelination even in the absence of the classical complement pathway. T cells and natural killer cells are relevant for intracortical type 2 but dispensable for subpial type 3 lesions, whereas CCR2+ monocytes are required for both. Depleting CCR2+ monocytes in marmoset monkeys with experimental autoimmune encephalomyelitis using a novel humanized CCR2 targeting antibody translates into significantly less cortical demyelination and disease severity. We conclude that biologics depleting CCR2+ monocytes might be attractive candidates for preventing cortical lesion formation and ameliorating disease progression in MS.


Assuntos
Córtex Cerebral/imunologia , Encefalomielite Autoimune Experimental/imunologia , Monócitos/imunologia , Esclerose Múltipla/imunologia , Adulto , Animais , Callithrix , Córtex Cerebral/patologia , Estudos de Coortes , Encefalomielite Autoimune Experimental/patologia , Feminino , Humanos , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/patologia , Masculino , Meninges/imunologia , Meninges/patologia , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Pessoa de Meia-Idade , Monócitos/patologia , Esclerose Múltipla/patologia , Distribuição Aleatória , Receptores CCR2/metabolismo , Linfócitos T/imunologia , Linfócitos T/patologia
3.
Case Rep Neurol ; 11(1): 1-3, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30792649

RESUMO

We report the first case of meningitis caused by Streptococcus agalactiae (group B streptococcus; GBS) after professional tooth cleaning in a previously healthy patient. GBS is a common commensal of the human gastrointestinal and vaginal flora. Although occurrence in the oral flora is unusual, oral transmission and thus occurrence can be assumed.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa